Evergrande Health Industrial Group (HK.0708) was listed on the main board of Hong Kong Stock Exchange, specializing in the high-end international hospital, the medical cosmetology & anti-aging and the medical maintenance industry.
Through cooperation with Harvard Medical School and other global top medical treatment and medical science institutions to construct the 'pyramid" of medical resources based on the community medical maintenance and led by the international high-end hospital, Evergrande Health Industrial Group has established the Tianjin WONJIN medical cosmetology flagship store with the total Korea team, and meanwhile, has established the international service standards to promote the large-scale, best- quality and standardized development strategy, providing more than 5 million Evergrande community residents and even more families in over 180 cities in China with the all-round and full-life-cycle health services.
In order to act in coordination with the establishment of the nation’s hierarchical system of medical service and in response to the call for greatly developing the service for the retired people, Evergrande Health starts from health management and service for the elderly, accurately orientates its 12 "Internet Plus" health management centers opened in the country, and provides the rehabilitation and the services for the retired in addition to the former community clinics. By combining the high-quality medical resources, it has created the community health service that focuses on disease prevention and covers primary diagnosis and treatment, Green Channel transfer and continuous control of chronic disease; the company provides timely services of rehabilitation and maintenance for the large number of the elderly at home and the suffering people; it also offers the third-party experts’ remote assistance online by the means of the Internet technology; as for the elderly’s security and dysfunction in their daily life as well as the risks caused by chronic illness, it combines different types of smart products to render the timely and accurate caring service in the home-based care for the aged and the reformed suit-elderly service.
On August 2015, Evergrande Health joined South Korea’s largest plastic surgery hospital - WONJIN Medical Cosmetology Group to start its business in the medical cosmetology industry. It has founded China’s first international medical cosmetology hospital that’s invested by the two country’s cross-border capital – Evergrande WONJIN Medical Cosmetology Hospital. Situated in Tianjin, the core of the Bohai economic circle, the hospital is orientated to upscale market.
Evergrande WONJIN Medical Cosmetology Hospital has set up the departments of cosmetic surgery, cosmetic dermatology, oral cavity cosmetology and traditional Chinese medical cosmetology, and it has introduced the world's top medical equipment, initiated the “Safety Cabin” eight systems, recruited the entire Korean “WONJIN ” team and been licensed with both China and South Korea certifications. Meanwhile, the hospital has also been locally transformed soon in conformity with the characteristics of the Asians, the customers’ psychological needs and China's legal environment in a quick manner, and it always adheres to the international first-class innovative service philosophy to build a new “landmark” in the field of Asian medical cosmetology.
Evergrande Health will establish small-scale medical cosmetology organizations in many of China’s major cities in the future and lay out the Evergrande medical cosmetology network that features Tianjin Evergrande WONJIN Medical Cosmetology Hospital’s focus on plastic surgery and specialized training, and that provides convenient, mild skin care and anti-aging services in the first and second-tier cities’ small-scale medical cosmetology organizations.
In view of the current situation of the rapidly aging population and the community residents’ needs to improve the quality of their life, Evergrande Health has started to develop its projects of large healthcare community, formulated the nation’s first living standards for healthcare at large-scale community, and it plans to build the health care ecosystem that includes family doctor, health management, rehabilitation, services for the elderly, community Internet Plus and O2O life. On the basis of this project, it will also expand others within the country.
So far, the first batch of healthcare community projects have been launched respectively in Haitang Bay and Ocean Flower Island in Sanya, Hainan, and they are scheduled for the first advance sale at the end of 2016. Meanwhile, Evergrande Health will also continue to develop new healthcare community projects in order to provide the wholly new experience for the elderly on travel.
Bo’ao Evergrande International Hospital is located in the Boao Lecheng International Medical Tourism Pilot Area in Hainan Province, the “pearl” on the South China Sea, and it’s an upscale international tumor hospital invested and incorporated by Evergrande Health, Brigham and Women's Hospital Affiliated to Harvard University and other well-known medical institutions home and abroad, in accordance with the international top-tier standards.
The hospital borrows and applies the advanced medical philosophy of multidisciplinary treatment, accurate and individualized treatment in Brigham and Women's Hospital Affiliated to Harvard University; it has introduced the cutting-edge model of tumor treatment and prevention such as gene detection and molecular diagnostics; through the platforms of the molecular medicine laboratory, the tumor immunology research center and the clinical pathology base, it has imported the world’s advanced diagnostic technology, treatment method and the newly launched medicine and equipment to provide the patients with the services of early prevention, early screening, second-time diagnosis, precise treatment and life-cycle rehabilitation.
When built up in the future, the hospital’s business will be opened to the whole country, cover the Southeast Asia region and directly reach the United States. It will be developed into the country’s internationally first-class tumor hospital that leads the industry trend and provides the life-cycle services and management from treatment, prevention to rehabilitation for tumor disease, contributing its strength to “Healthy China”.